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Low back pain (LBP) is a highly prevalent and burden-
some health problem worldwide and the leading cause 
of disability in most countries.1,2) Its high recurrence rate 
within 1 year after recovery from a previous episode is a 
key contributor to the recognition of LBP as the public 
health burden.3-5) Smoking has been suggested as a risk 
factor for LBP.6,7) However, evidence on the role of smok-
ing in the development of LBP is inconsistent,8-10) and the 
exact nature of that link has been largely untested in long-
term cohort studies. 
In a recent meta-analysis10) of 40 studies examining 
the relationship between smoking and LBP, current smok-
ers had a 31% higher risk of LBP than nonsmokers, but 
that estimate applied only the preceding 12 months. None 
of the included studies were designed to determine wheth-
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er there is a cause and effect relationship, which cannot be 
established in a randomized controlled trial due to ethical 
concerns. Therefore, the most feasible study design for as-
sessing the relationship in humans is a cohort study. 
Another systematic review demonstrated that the 
data were fairly consistent with the notion that smoking 
is associated with LBP, but there were too few studies to 
make any conclusions regarding other conditions, such 
as disc degeneration, herniated discs, and sciatica.8) Fur-
thermore, no large registry study has so far investigated 
the association between smoking and LBP-related lumbar 
spine diseases, such as intervertebral disc disease, spinal 
stenosis, spinal instability, or spondylolisthesis. We, there-
fore, reviewed a random sample taken from the Korean 
National Health Insurance Research Database with the 
aim of investigating whether smoking can be a potential 
risk for LBP and related spinal diseases and, in particular, 
whether the risk is higher in the smokers (exposure group) 
than nonsmokers (non-exposure group). 
METHODS
The Korean National Health Insurance Service (NHIS) has 
provided a national health screening program since 1995. 
The NHIS constructed a sample cohort database in 2015 
to offer relevant, useful data for health research, especially 
in the field of noncommunicable diseases and health 
risk factors. For this study, we used this database, which 
is registered as the NHIS-Health Screening Cohort. We 
conducted this study in compliance with the principles of 
the Declaration of Helsinki. The protocol of this study was 
reviewed and approved by the Institutional Review Board 
and Ethics Committee of National Health Insurance Ser-
vice Ilsan Hospital (IRB No. 2015-02-037). The informed 
consent was waived. 
Study Population
The cohort was first selected from the 2002 and 2003 
health screening participants, who were aged between 40 
years and 79 years in 2002 and followed up through 2013. 
This initial cohort included 514,866 health screening par-
ticipants who comprised 10% of a simple random sample 
of all national health screening participants in 2002 and 
2003. The database meets the high demand for research 
requiring both health screening data and long-term health 
outcomes including detailed information on medical 
treatment, health screening, and socioeconomic variables 
(residence, death date, cause of death, and income level). 
The complete profile of the cohort has been published re-
cently.11)
To minimize the possibility of selection bias, we ex-
cluded 181,766 patients (74,466 men and 107,300 women) 
diagnosed as having back pain or spinal diseases during 
the first 2 years (2002–2003). We also excluded 911 partic-
ipants (593 men and 318 women) whose baseline smoking 
status was unknown. The proportion of women who re-
ported themselves as smokers was too small (7,204, 5.6%), 
compared to that of male participants, to produce statisti-
cally relevant results. Therefore, we excluded all women 
from analysis. Finally, the investigated cohort consisted of 
204,066 men (160,105 smokers and 43,961 nonsmokers) 
(Fig. 1).
Data Collection
Health screening participants undergo standardized ex-
aminations per 2 years. During visits, they report their 
smoking habits, medical history, alcohol consumption, 
and physical activity. Weight and height are measured in 
light clothing. Blood pressure is measured in a seated posi-
tion. Blood samples are obtained after an overnight fast 
for white cell count and clinical chemical analysis. Quality 
128,123 Excluded
Women (because of
the small proportion of women
reported having smoked)
160,105 Smokers
(former and current smokers)
43,961 Nonsmokers
514,866 Participants (aged 40 to 79 years) who
underwent health screening in 2002 and 2003 from
the Korean National Health Insurance Databases
332,189 Participants available for follow-up
through 2013
204,066 Male eligible participants
182,677 Excluded
181,766 Preexisting back pain
or any spinal diseases during
2 years (2002 2003)
911 Missing data regarding
smoking status
Fig. 1. Flowchart of study population se-
lection.
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control procedures are performed in accordance with the 
guidelines of the Korean Association of Laboratory Qual-
ity Control.
Information on smoking was obtained from all par-
ticipants at least once between 2002 and 2013. All smoking 
data were self-reported. The health examination ques-
tionnaire contains questions about smoking history, the 
number of cigarettes consumed per day, years of smoking 
duration, and years since cessation. The responses in serial 
follow-up questionnaires were used to model smoking as 
a time-dependent variable. Former smokers and partici-
pants who had never smoked did not complete follow-up 
questionnaires reflecting their smoking history (we did 
not censor these data). We censored the data of current 
smokers on the date of the second missed questionnaire to 
prevent misclassifying those who might have quit smok-
ing.
Ascertainment of LBP and Other Outcomes
The primary outcome was LBP and four common lumbar 
or lumbosacral spinal diseases—intervertebral disc dis-
ease, spinal stenosis, spinal instability, and spondylolisthe-
sis. All diagnoses of LBP and the four spinal diseases de-
scribed in the International Classification of Diseases and 
Related Health Problems, Tenth Revision (ICD-10) were 
included. We excluded back pain or spinal diseases attrib-
uted to inflammatory, infectious, traumatic, neoplastic, 
deformed, or congenital causes. The site of involvement 
was restricted to lumbar or lumbosacral by supplementary 
subclassifications, which were provided for optional use in 
the appropriate categories in the block on spondylopathy, 
except in categories M51 and M54.5. The final analysis 
included five outcomes: LBP (M54.5) and four common 
lumbar or lumbosacral spinal diseases—intervertebral disc 
disorders (M51), spinal stenosis (M4806, M4807), spinal 
instability (M5326, M5327), and spondylolisthesis (M4316, 
M4317). We tried to minimize the effect of previous back 
pain or any spinal diseases (M40–M54) on the baseline 
by excluding all events that occurred during the first two 
years of follow-up (2002 and 2003). Thus, general follow-
up began on January 1 of the 3rd year after the baseline 
visit.
Statistical Analysis
To investigate differences between smoking exposure (smok-
er) and non-exposure (nonsmoker) groups, the Fisher 
exact test was used for categorical variables and the t-test 
for continuous variables if normally distributed; if not, 
the Mann-Whitney test was used. For a given covariate, a 
standardized difference of less than 10% indicates a rela-
tively small imbalance.12) Event rates per 10,000 person-
years were calculated as number of events divided by total 
follow-up time until the event, death, or censoring per 
10,000 years, with 95% confidence intervals (CIs) esti-
mated by assuming Poisson distribution. The difference 
between two event rates was tested by assuming approxi-
mately normal distribution of the estimates with the Z test 
statistic. We calculated unadjusted rates of LBP and the 
four lumbar spinal diseases per person-year and produced 
Kaplan-Meier survival curves (survival and rms packages, 
R software, ver. 3.3.2, The R Foundation, Vienna, Austria) 
for smoking status.
To compare the risk of LBP and related lumbar 
spinal diseases between the groups, a Cox proportional 
hazards model starting at baseline was used. We modeled 
time to event. The Cox regression model used the length 
of each individual’s follow-up period. Follow-up for all 
participants began at the time of the original health ex-
amination between 2002 and 2003 and was concluded on 
the date of development of any of the morbidities, which 
is the date on which data were censored, or December 31, 
2013, whichever came first. Cox analyses were performed 
for LBP, intervertebral disc disease, spinal stenosis, spinal 
instability, and spondylolisthesis. In these analyses, we 
compared the morbidity risk in the smoker (former and 
current smokers) group with that in the nonsmoker group. 
The multivariable Cox model was adjusted for the 
age at enrollment (continuous variable), body mass index 
(continuous variable), alcohol consumption (five catego-
ries based on frequency: never, 2–3 per month, 1–2 per 
week, 3–4 per week, and everyday), physical activity (five 
categories based on frequency: never, 1–2 per week, 3–4 
per week, 5–6 per week, and everyday), socioeconomic 
status (three categories based on income: high, middle, 
and low), total cholesterol (continuous variable), and 
blood sugar (continuous variable). All analyses were ac-
complished using SAS ver. 9.4 (SAS Institute, Cary, NC, 
USA). 
RESULTS
The standardized differences between the groups were 
below 10% for all investigated baseline characteristics ex-
cept for the mean age, alcohol consumption, and physical 
activity (Table 1). The smoker group was slightly younger 
than the nonsmoker group with standardized difference 
of 24.7%. More alcohol consumption and physical activity 
were reported in the smoker group than in the nonsmoker 
group, with a difference of 55.3% and 17.9%, respectively. 
The overall median follow-up period of all 72,814 patients 
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who developed LBP or the four lumbar spinal diseases was 
5.6 years (interquartile range [IQR], 3.48 to 8.43 years). 
The overall mean age at the time of the event was 56.6 ± 8.9 
years. There were 44,937 patients with LBP, 20,194 patients 
with intervertebral disc disease, 4,412 patients with spinal 
stenosis, 4,585 patients with spinal instability, and 1,143 
Table 1. Baseline Demographic Characteristics of Male Participants According to Smoking Status
Characteristic Nonsmoker group (n = 43,961) Smoker group (n = 160,105) Standardized difference (%)
Pack-year - 18.59 (8.63–25.88)
Age (yr) 56.53 ± 9.99 54.18 ± 8.99 24.7
Body mass index (kg/m2) 24.15 (22.27–25.95) 23.95 (22.05–225.77)   7.0
Blood chemistry 
Blood sugar 100.32 (84–105) 101.08 (85–2106)   2.2
Total cholesterol  196.69 (172–219) 198.10 (173–2221)   3.8
SGOT (AST) 28.64 (21–31) 29.04 (18–234)   2.0
SGPT (ALT) 29.49 (18–34) 29.82 (18–234)   1.4
Medical history*
Hypertension 2,435 (7.1) 7,743 (6.2)   3.7
Heart disease  332 (1.0) 1,153 (0.9)   0.5
Stroke  180 (0.5)  428 (0.3)   2.8
Diabetes 1,306 (3.8) 4,417 (3.5)   1.5
Alcohol consumption*
Nondrinker 21,549 (49.2)  40,207 (25.2) 55.3
   2–3 Drinks per month  8,089 (18.5)  30,504 (19.1)
   1–2 Drinks per week  9,085 (20.7)  51,839 (32.5)
   3–4 Drinks per week 3,204 (7.3)  23,769 (14.9)
   Everyday drinker 1,907 (4.4) 13,390 (8.4)
Physical activity (exercise frequency)* 17.9
   None 19,933 (46.3) 64,469 (40.4)
   1–2 Per week 12,991 (30.2) 46,535 (29.2)
   3–4 Per week  4,989 (11.6) 20,483 (12.8)
   5–6 Per week 1,345 (3.1) 6,797 (4.3)
   Everyday 3,774 (8.8) 21,202 (13.3)
Socioeconomic status†   6.9
   High 18,320 (41.7) 61,312 (38.3)
   Middle 15,326 (34.9) 39,288 (24.5)
   Low 10,315 (23.5) 59,505 (37.2)
Values are presented as mean ± standard deviation, mean (interquartile range), or number (%).
SGOT: serum glutamic oxaloacetic transaminase, AST: aspartate transaminase, SGPT: serum glutamic pyruvic transaminase, ALT: alanine transaminase.
*Medical history, alcohol consumption, and physical activity were self-reported. †Socioeconomic status was classified into three categories based on 
income.
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Table 2. Risk of Low Back Pain and Related Low Back Spinal Diseases According to Smoking Status in Men
Variable Nonsmoker group (n = 43,961) Smoker group (n = 160,105) p-value
Low back pain (M545)
   Median duration of follow-up (IQR), yr 5.89 (3.62–8.74)
   No. (%) 9,654 (21.96) 35,283 (22.04) 0.01
   Incidence rate per 10,000 person-year (95% CI) 473.08 (463.64–482.52) 1729.00 (1710.96–1747.04) 0.01
   Difference per 10,000 person-year (95% CI) Reference 1255.92 (1255.76–1256.07) <0.001
   Multivariable-adjusted HR per year (95% CI)* 1 (Reference) 1.18 (1.15–1.21) <0.001
Intervertebral disc disease (M51)
   Median duration of follow-up (IQR), yr 4.79 (3.14–7.40)
   No. (%) 4,180 (9.51) 16,014 (10.00) <0.001
   Incidence rate per 10,000 person-year (95% CI) 204.84 (198.63–211.05) 784.75 (772.60–796.90) <0.001
   Difference per 10,000 person-year (95% CI) Reference 579.91 (579.81–580.01) <0.001
   Multivariable-adjusted HR per year (95% CI)* 1 (Reference) 1.25 (1.21–1.30) <0.001
Spinal stenosis (M4806, M4807)
   Median duration of follow-up (IQR), yr 7.64 (5.50–9.73)
   No. (%) 931 (2.12) 3,481 (2.17) 0.004
   Incidence rate per 10,000 person-year (95% CI) 45.62 (42.69–48.55) 170.58 (164.91–176.25) 0.004
   Difference per 10,000 person-year (95% CI) Reference 124.96 (124.91–125.01) <0.001
   Multivariable-adjusted HR per year (95% CI)* 1 (Reference) 1.52 (1.41–1.64) <0.001
Spinal instability (M5326, M5327)
   Median duration of follow-up (IQR), yr 4.94 (3.26–7.58)
   No. (%) 915 (2.08) 3,670 (2.29) <0.001
   Incidence rate per 10,000 person-year (95% CI) 44.84 (41.93–47.75) 179.84 (174.02–185.66) <0.001
   Difference per 10,000 person-year (95% CI) Reference 135.01 (134.95–135.06) <0.001
   Multivariable-adjusted HR per year (95% CI)* 1 (Reference) 1.33 (1.24–1.44) <0.001
Spondylolisthesis (M4316, M4317)
   Median duration of follow-up (IQR), yr 6.66 (4.94–8.71)
   No. (%) 243 (0.55) 900 (0.56) 0.023
   Incidence rate per 10,000 person-year (95% CI) 11.91 (10.41–13.41) 44.10 (41.22–46.98) 0.023
   Difference per 10,000 person-year (95% CI) Reference 32.20 (32.17–32.22) <0.001
   Multivariable-adjusted HR per year (95% CI)* 1 (Reference) 1.49 (1.23–1.80) <0.001
IQR: interquartile range, CI: confidence interval, HR: hazard ratio.
*HRs were estimated from Cox proportional hazards models adjusted for age, body mass index, total cholesterol, blood sugar, alcohol consumption (five 
categories based on frequency: never, 2–3 per month, 1–2 per week, 3–4 per week, and everyday), physical activity (five categories based on frequency: 
never, 1–2 per week, 3–4 per week, 5–6 per week, and everyday), and socioeconomic status (three categories based on income: high, middle, and low).
205
Kwon et al. Prevalence of Spinal Disease among Smokers in Korea
Clinics in Orthopedic Surgery • Vol. 12, No. 2, 2020 • www.ecios.org
patients with spondylolisthesis. After a median follow-up 
of 5.9 years (IQR, 3.6 to 8.7 years), there were 35,283 cases 
of LBP in the smoker group and 9,654 cases of LBP in the 
nonsmoker group, corresponding to incidence rates of 
1,729.00 (95% CI, 1,710.96 to 1,747.04) and 473.08 (95% 
CI, 463.64 to 482.52) cases of LBP per 10,000 person-
years, with an absolute rate difference of 1,255.92 (95% CI, 
1,255.76 to 1,256.07). The incidence of each of the four 
spinal diseases (intervertebral disc disease, spinal stenosis, 
spinal instability, and spondylolisthesis) was also higher in 
the smoker group, with a higher incidence rate per 10,000 
person-years and an absolute rate difference (Table 2).
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Fig. 2. The cumulative incidence of low 
back pain by smoking exposure status in 
the male cohort (204,066 men older than 
40 years) during the 10-year follow-up. 
The shading denotes 95% confidence 
intervals. The number of participants at 
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Fig. 3. The cumulative incidence of in-
tervertebral disc disease by smoking 
exposure status in the male cohort 
(204,066 men older than 40 years) during 
the 10-year follow-up. The shading 
denotes 95% confidence intervals. The 
number of participants at risk and cu-
mulative person-years are also shown.
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In an unadjusted Cox model, the smoker group 
showed a higher cumulative incidence of LBP from 8 years 
after the start of follow-up than the nonsmoker group 
(Fig. 2). The smoker group also had a higher incidence 
of intervertebral disc disease from 4 years (Fig. 3), spinal 
stenosis from 5 years (Fig. 4), spinal instability from 1 year 
(Fig. 5), or spondylolisthesis from 3 years (Fig. 6). In a 
multivariable-adjusted Cox model, the hazard ratio (HR) 
for LBP was higher in the smoker group (HR, 1.18; 95% 
CI, 1.15 to 1.21), intervertebral disc disease (HR, 1.25; 95% 
CI, 1.21 to 1.30), spinal stenosis (HR, 1.52; 95% CI, 1.41 
to 1.64), spinal instability (HR, 1.33; 95% CI, 1.24 to 1.44), 
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Fig. 4. The cumulative incidence of spinal 
stenosis by smoking exposure status in 
the male cohort (204,066 men older than 
40 years) during the 10-year follow-up. 
The shading denotes 95% confidence 
intervals. The number of participants at 
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Fig. 5. The cumulative incidence of spinal 
instability by smoking exposure status 
in the male cohort (204,066 men older 
than 40 years) during the 10-year follow-
up. The shading denotes 95% confidence 
intervals. The number of participants at 
risk and cumulative person-years are also 
shown.
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and spondylolisthesis (HR, 1.49; 95% CI, 1.23 to 1.80) as 
compared with the nonsmoker group (Table 2).
DISCUSSION
In this retrospective cohort study of males aged 40 years 
and older, we found that the smoker group had a higher 
cumulative risk of developing LBP or lumbar spinal disor-
ders such as intervertebral disc disease, spinal stenosis, spi-
nal instability, and spondylolisthesis. The adjusted risk rate 
was the highest in individuals with spinal stenosis (52%) 
and spondylolisthesis (49%). To the best of our knowledge, 
this is the first study to investigate whether smokers are at 
higher risk than nonsmokers for four common back prob-
lems, such as intervertebral disc disease, spinal stenosis, 
spinal instability, and spondylolisthesis. In a recent meta-
analysis of three cohort studies, smokers showed an overall 
24% risk increase in LBP development; however, the sam-
ple size (2,490 in total) was smaller than that in this study, 
and these groups were not selected in the general popula-
tion (occupational).5,13-15) Unlike these studies, our study 
utilized a large, longitudinal, contemporary dataset of ran-
domly selected national cohorts. Another strength of this 
study is that the size of the initial cohort (n = 514,866) was 
sufficient to select a well-balanced control group and the 
study design was appropriate to investigate the association 
between smoking and primary outcomes. To minimize the 
possibility of selection bias in retrospective cohort studies, 
we analyzed data after a 2-year clearance of patients with 
existing spinal disorders and back pain conditions. Fur-
thermore, adjustments were made to anthropometric vari-
ables, clinical risk factors, and comorbidities. The use of 
lifestyle and socioeconomic data allowed adequate consid-
eration of confounding factors. There are some limitations 
to this study. First, the retrospective observational design 
interfered with the evaluation of causality. Second, the reli-
ability of specific information related to smoking was lim-
ited because it was based on self-reported data. Third, the 
analysis was confined to men because the percentage of 
female smokers (6%) was too small to produce statistically 
meaningful results. Perhaps the reason for the low number 
of female smokers in this study is that female smokers are 
traditionally few in Korea and Korean women are reluc-
tant to disclose their smoking status for social and cultural 
reasons. If the number of female smokers was sufficient 
to make a statistically meaningful analysis as in males, 
the effect of female smoking on the main outcome is not 
expected to be significantly different from male smoking. 
Fourth, the median follow-up period of the present study 
was 5.6 years, which is relatively longer than that in other 
studies. Still, it may not be enough time to investigate the 
incidence of LBP and related spinal diseases. A long-term 
follow-up of at least 10 or 20 years will clearly show the 
impact of smoking on the development of these diseases. 
Fifth, since participants of this study were mainly Asians, 
the results obtained from this study may not be general-
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Fig. 6. The cumulative incidence of spon-
dylolisthesis by smoking exposure status 
in the male cohort (204,066 men older 
than 40 years) during the 10-year follow-
up. The shading denotes 95% confidence 
intervals. The number of participants at 
risk and cumulative person-years are also 
shown.
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ized to other populations.
In conclusion, smokers in male samples were at 
higher risk for LBP and related spinal diseases (interver-
tebral disc disease, spinal stenosis, spinal instability, and 
spondylolisthesis) than nonsmokers. Although the gen-
eralizability of our findings may be limited because of the 
observational study design and male-specific data, the re-
sults suggest that smoking can be a potential risk for LBP 
and related spinal diseases. Prospective cohort studies that 
involve at least 10 years of follow-up are needed to confirm 
our findings.
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